296 related articles for article (PubMed ID: 16241992)
1. Breast pathology practice: most common problems in a consultation service.
Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
[TBL] [Abstract][Full Text] [Related]
2. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
3. Papillary lesions of the breast: selected diagnostic and management issues.
Collins LC; Schnitt SJ
Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
[TBL] [Abstract][Full Text] [Related]
4. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
5. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
6. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
7. Papillary lesions of the breast.
Ibarra JA
Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic pitfalls in mammary pathology. Case 1. In situ ductal carcinoma of low nuclear grade, with papillary, micropapillary and cribriform architecture].
MacGrogan G
Ann Pathol; 2009 Jun; 29(3):188-93. PubMed ID: 19619824
[No Abstract] [Full Text] [Related]
9. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
Lee AH
J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
[TBL] [Abstract][Full Text] [Related]
10. The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Moriya T
J Clin Pathol; 2009 May; 62(5):407-13. PubMed ID: 19126567
[TBL] [Abstract][Full Text] [Related]
11. Breast papillomas with atypical ductal hyperplasia: a clinicopathologic study.
Raju U; Vertes D
Hum Pathol; 1996 Nov; 27(11):1231-8. PubMed ID: 8912836
[TBL] [Abstract][Full Text] [Related]
12. Artefactual Epithelial Displacement in a Papilloma with Extensive Usual Duct Hyperplasia Mimics a Solid Papillary Carcinoma with Invasive Growth.
François A; Galant C; Berlière M; Van Bockstal MR
Int J Surg Pathol; 2021 Jun; 29(4):395-399. PubMed ID: 33736513
[TBL] [Abstract][Full Text] [Related]
13. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.
MacGrogan G; Arnould L; de Mascarel I; Vincent-Salomon A; Penault-Llorca F; Lacroix-Triki M; Bibeau F; Baranzelli MC; Fridman V; Antoine M; Bécette V; Brouste V; Jacquemier J; Mathoulin-Pélissier S;
Histopathology; 2008 May; 52(6):689-97. PubMed ID: 18397281
[TBL] [Abstract][Full Text] [Related]
14. Significance of papillary lesions at percutaneous breast biopsy.
Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
[TBL] [Abstract][Full Text] [Related]
15. Malignant breast lesions that may mimic benign tumors.
Weidner N
Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Masood S; Sim SJ; Lu L
Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
[TBL] [Abstract][Full Text] [Related]
19. Borderline breast lesions: diagnostic challenges and clinical implications.
Masood S; Rosa M
Adv Anat Pathol; 2011 May; 18(3):190-8. PubMed ID: 21490436
[TBL] [Abstract][Full Text] [Related]
20. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]